SSRIs and upper gastrointestinal bleeding: what is known and how should it influence prescribing?
about
Evaluation of risk factors in patients with vitamin K-dependent coagulopathy presumed to be caused by exposure to brodifacoum.The use of antidepressants and the risk of haemorrhagic stroke: a nested case control studyWarfarin toxicity and individual variability-clinical case.Incident user cohort study of risk for gastrointestinal bleed and stroke in individuals with major depressive disorder treated with antidepressants.Effect of age, weight, and CYP2C19 genotype on escitalopram exposure.Selective serotonin reuptake inhibitors: measurement of effect on platelet functionSSRI-induced coagulopathy: is it reality?Myths and facts in the use of anti-inflammatory drugs.Identifying and assessing benefit-risk in primary care--a family physician's perspective.Clinically significant drug interactions with newer antidepressants.Clinically relevant drug interactions in anxiety disorders.Antidepressant use in the elderly: the role of pharmacodynamics and pharmacokinetics in drug safety.Safety of selective serotonin reuptake inhibitor treatment in recovering stroke patients.Upper gastrointestinal bleeding in a patient with depression receiving selective serotonin reuptake inhibitor therapy.Serotonin reuptake inhibitors and post-gastrostomy bleeding: reevaluating the link.Preadmission use of SSRIs alone or in combination with NSAIDs and 30-day mortality after peptic ulcer bleeding.Consultation-liaison psychiatry for patients with headaches.Suppressive effect of citalopram on plasma concentrations of thromboxane B2.Identification and weighting of the most critical "real-life" drug-drug interactions with acenocoumarol in a tertiary care hospital.Sertraline-induced periorbital purpura: a case report.Outcome of peptic ulcer bleeding among users of traditional non-steroidal anti-inflammatory drugs and selective cyclo-oxygenase-2 inhibitors
P2860
Q33912911-39F86FFB-6263-45CD-95A0-AF544B48FBB1Q34476123-75C1DE45-6B39-4DF6-A730-3E8BE65BFBD4Q35155651-EDFAE995-5AF3-46D9-825B-510829879EA5Q35899461-61111227-D85B-47E8-95B1-92B85296C49FQ36606190-D5105CC9-8CBC-46B8-A52A-0033C72BD89FQ36667962-5D6A52B8-5006-4800-A265-EFAE1B04EA65Q37078974-EC95B01D-8FE0-4E12-94C7-8DBE42269E1FQ37476911-B8185A35-B6A0-44A3-94D8-9C17F2EFC93BQ37734731-F543FB01-5C41-4F7C-BC4C-60674241BDB6Q37968621-15A84440-D758-4FB3-9173-90E2953A6818Q37981951-F593C270-C727-4D10-8310-BA9123CE21E3Q38367401-D167EEB7-3EB1-44BA-960B-F330456A74ABQ38402064-E88CBCED-6637-481C-AB2D-0FBDEA46A337Q42117226-D9F1BCE7-C79E-416B-AEFA-10A06B2324E6Q42127953-D83908E3-B47B-40FE-8671-A5FC8A9999ABQ43248032-9166BA04-A103-4809-AF3F-37F667E0AEFCQ45907140-3CD8128F-05E7-41D6-87DF-7B00F25F8B16Q48077623-A9AF4A1F-CC9B-4ECE-B56B-0200660AC437Q50918683-DFC706DD-7851-4A5A-8D15-BFCCDBD79A49Q51025625-4387C598-F26E-48CB-AFF3-BA25C6F213C1Q57300663-8D46E1B2-8D5B-4270-BFCD-0144FF1ABCA9
P2860
SSRIs and upper gastrointestinal bleeding: what is known and how should it influence prescribing?
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
SSRIs and upper gastrointestin ...... ould it influence prescribing?
@ast
SSRIs and upper gastrointestin ...... ould it influence prescribing?
@en
type
label
SSRIs and upper gastrointestin ...... ould it influence prescribing?
@ast
SSRIs and upper gastrointestin ...... ould it influence prescribing?
@en
prefLabel
SSRIs and upper gastrointestin ...... ould it influence prescribing?
@ast
SSRIs and upper gastrointestin ...... ould it influence prescribing?
@en
P50
P1433
P1476
SSRIs and upper gastrointestin ...... ould it influence prescribing?
@en
P2860
P304
P356
10.2165/00023210-200620020-00005
P577
2006-01-01T00:00:00Z
P6179
1015219212